Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Hematologic Diseases × Dacarbazine × 1 year × Clear all

Sponsor

Conditions

Hodgkin Disease 16 Melanoma 6 Sarcoma 3 Neoplasms 2 Lymphoma 2 Leiomyosarcoma 2 Uveal Melanoma 1 Sarcoma, Synovial 1 Sarcoma, Alveolar Soft Part 1 Lung Neoplasms 1 Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8 1 Kidney Neoplasms 1 Immunotherapy 1 Hyperthermia 1 Colonic Neoplasms 1 Breast Neoplasms 1 Advanced Melanoma 1

Interventions

pirtobrutinib 6 Mycophenolic Acid 5 Cyclophosphamide 5 fludarabine phosphate 4 Rituximab 4 Melphalan 4 Azacitidine 4 ibrutinib 3 fludarabine 3 Whole-Body Irradiation 3 Tacrolimus 3 Mesna 3 venetoclax 2 Peripheral Blood Stem Cell Transplantation 2 Patient Reported Outcome Measures 2 Cyclosporine 2 Busulfan 2 Brentuximab Vedotin 2 Bone Marrow Transplantation 2 Blood Specimen Collection 2 Bendamustine Hydrochloride 2 zanubrutinib 1 spartalizumab 1 sabatolimab 1 ruxolitinib 1 ponatinib 1 pembrolizumab 1 nilotinib 1 idelalisib 1 cedazuridine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡